Medical Cannabis

Pharmaseed: your one-stop shop partner for medical cannabis research –

 

Medical cannabis studies are performed in our laboratories in Israel

 

Testing For Clinical Relevant Indications

 

• Multiple Sclerosis
• Glaucoma
• ALS
• Peripheral Neuropathic Pain
• Post Operative Pain
• Spinal Cord Injury
• Anxiety – PTSD
• Parkinson’s Disease
• Cachexia, Nausea& Vomiting – Cancer
• Rheumatoid Arthritis
• Inflammatory Bowel Diseases
• Epilepsy

 

Pharmacology: full analysis capabilities

 
• Analysis of cannabinoids composition (CBD vs THC); bioinformatic evaluation
• Binding and activity assays CB1/CB2 (cAMP)
• Full panel receptor profile binding
• Basic efficacy in vitro assays
• Animal disease efficacy studies [POC]
• Basic safety (in vivo and in vitro): GLP & non–GLP

Formulation: on-site development and optimization

• Optimization of the bioavailability
and delivery standardization, based
on the selected clinical indication
• Development of standard carrier
(formulation) that will address
stability and delivery unmet
needs:sublingual, cream/patches,
etc.

 

Monetizing your cannabis-derived drug development program

 

A successful medical cannabis drug development requires a perfectly tailored pre-clinical program that will add technological value to your IP rights. Understanding your technology, matching it with the most appropriate clinical models so it will translate into clinical indications.

  • Categories:
    Cannabis

Share this expertise